UBS analyst AJ Rice raised the firm’s price target on Universal Health (UHS) to $320 from $302 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health Granted New Trial in Nevada Verdict
- Universal Health price target raised to $215 from $190 at BofA
- Sell Rating on Universal Health: Weaker Underlying Demand, Policy Risks, and Overvalued Shares Support Underperform Stance
- Universal Health price target raised to $268 from $262 at Barclays
- Closing Bell Movers: Nvidia pares post-earnings gains